NCT02127775View on ClinicalTrials.gov

Lesinurad Tablet Bioequivalence

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

July 31, 2014

Conditions
Healthy
Interventions
DRUG

Lesinurad 400 mg (manufactured at Site 1)

DRUG

Lesinurad 400 mg (manufactured at Site 2)

Trial Locations (1)

78744

Austin

Sponsors
All Listed Sponsors
lead

Ardea Biosciences, Inc.

INDUSTRY

NCT02127775 - Lesinurad Tablet Bioequivalence | Biotech Hunter | Biotech Hunter